Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vincent Shu"'
Autor:
Yohei Torigoe, Adam Lyons, Dai Tsunoda, Yasuaki Horima, Brian Dillon, Kurt E. Wampler, Tom Wallow, Zhang Quan, Vincent Shu
Publikováno v:
Photomask Technology 2020.
MPC computation time is basically in proportional to the number of vertices in the layout. ILT free form may have up to 15 times more vertices than conventional OPC output, which may lead to the ballooning of MPC processing time. Novel data simplific
Autor:
Shuichiro Ohara, Stanislas Baron, Yasuaki Horima, Yasuko Saito, Been-Der Chen, Chris Spence, Zhang Quan, Vincent Shu, Masakazu Hamaji
Publikováno v:
Photomask Technology.
To achieve the ultimate resolution and process control from an optical (193i 1.35NA) scanner system, it is desirable to be able to exploit both source and mask degrees of freedom to create the imaging conditions for any given set of patterns that com
Autor:
Sanjay Kapasi, Vincent Shu, Hui Zhou, Chris Aquino, Ying Gong, Yang Ping, Jun Ye, Jianhong Qiu, Jian Liu, Taksh Pandey, Pengcheng Li, Yee Mei Foong, Sarah McGowan, Bo Yan, Jiao Liang, Stanislas Baron
Publikováno v:
SPIE Proceedings.
At the 20nm technology node, it is challenging for simple resolution enhancements techniques (RET) to achieve sufficient process margin due to significant coupling effects for dense features. Advanced computational lithography techniques including So
Autor:
Carrie Sadd, Ken Kashkin, John J. Sramek, Sara Kennedy, Olga Jasinsky, Vincent Shu, Neal R. Cutler, Stephen Chang
Publikováno v:
Depression. 2:315-318
ABT-200 is a novel potential antidepressant which antagonizes both norepi-nephrine uptake and noradrenergic alpha-2 receptors. Patients who met DSM-III-R criteria for major depressive disorder and continued to meet all inclusion criteria following a
Publikováno v:
American journal of ophthalmology. 149(4)
Purpose To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of ophthalmic formulations of bimatoprost 0.01% and 0.0125% compared with bimatoprost 0.03%. Design Prospective, randomized, double-masked, multicenter clinical trial. Me
Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 2006.
Includes bibliographical references (p. 83-84).
This thesis describes a course scheduling system that models planning as a
Includes bibliographical references (p. 83-84).
This thesis describes a course scheduling system that models planning as a
Externí odkaz:
http://hdl.handle.net/1721.1/37092
Autor:
Claus Peckelsen, James C. Stolzenbach, Ville Pettilä, Vincent Shu, Stuart Simon, Abla A. Creasey, Christopher J. Doig, Edward Abraham, Russell Postier, Bruce Light, Konrad Reinhart, Judy Stone, Herbert Spapen, Charles L. Sprung, Petr Svoboda, Lona Poole, Jeffrey Tobias, Sandra Percell, Steven M. Opal, Ignace Demeyer, Cathy De Deyne, Allan Seibert, Christian Zwingelstein, Antonio Artigas, Pierre-François Laterre, Angel López Rodriguez, Richard Beale
Publikováno v:
JAMA. 290(2)
Context The expression and release of tissue factor is a major trigger for the activation of coagulation in patients with sepsis. Tissue factor pathway inhibitor (TFPI) forms a complex with tissue factor and blood protease factors leading to inhibiti
Autor:
Konrad Reinhart, Thomas Butler, Christian Zwingelstein, Sandra Percell, Abla A. Creasey, Petr Svoboda, Anthony R. Dal Nogare, Derk Olthoff, Gunter Hempelmann, Allan Seibert, Russell Postier, Anton Leighton, Eike Martin, Edward Abraham, Vincent Shu
Publikováno v:
Critical care medicine. 29(11)
To identify a safe and potentially effective recombinant tissue factor pathway inhibitor (rTFPI) dose for further clinical evaluation in patients with severe sepsis.Prospective, randomized, single-blind, placebo-controlled, dose escalation, multicent